Deputy Director for Cancer Research and Technology , Office of the Vice President
Jerry S.H. Lee, PhD is the Deputy Director for Cancer Research and Technology for the Cancer Moonshot Task Force. Prior to this role, he has spent the last decade in the National Cancer Institute (NCI) Office of the Director developing and implementing over a dozen large-scale advanced technology initiatives as the Deputy Director of NCI's Center for Strategic Scientific Initiatives. Prior to joining the NCI, his research involved elucidating mechanisms of age-related diseases and has co-authored over twenty papers, five book chapters, and one book. He continues his research as an adjunct associate professor at Johns Hopkins University, where he also earned his bachelor's degree in biomedical engineering and Ph.D. in chemical and biomolecular engineering. Dr. Lee also holds an appointment at the Washington D.C. Veterans Affairs Medical Center and collaborates with clinicians on next generation patient-centered outcomes research. He is a member of the Innovation Policy Forum of the National Academies Board on Science, Technology, and Economic Policy, the Foundation for the NIH's Biomarkers' Consortium Cancer Steering Committee, the Health and Environmental Sciences Institute's Board of Trustees, and the editorial board of the Convergence Science Physical Oncology journal.
Associate Professor, Icahn School of Medicine at Mount Sinai, New York
Joel Dudley is a recognized leader in applying biomedical big data to healthcare and drug discovery. He currently holds positions as Associate Professor of Genetics and Genomic Sciences and Director of Biomedical Informatics at the Icahn School of Medicine at Mount Sinai. He also directs the newly formed Institute for Next Generation Healthcare at Mount Sinai. Prior to Mount Sinai, he held positions as Co-founder and Director of Informatics at NuMedii, Inc., one of the first companies to apply big data to drug discovery, and Consulting Professor of Systems Medicine in the Department of Pediatrics at Stanford University School of Medicine. His work is focused on developing and applying advanced computational methods to integrate the digital universe of information to build better predictive models of disease, drug response. He and his team are also developing pioneering methods to bring about a next generation of medicine that leverages advances in diagnostics, wearables, digital health to enable new approaches to precision medicine and scientific wellness. He has authored and co-authored more than 80 publications and his research has been featured in the Wall Street Journal, Scientific American, Forbes, and other popular media outlets. His recent work using a Big Data approach to identify sub-types of Type 2 diabetes was recently highlighted by NIH director Francis Collins on the the NIH Director's Blog as a significant advance in precision medicine. He was named in 2014 as one of the 100 most creative people in business by Fast Company magazine. He is co-author of the book Exploring Personal Genomics from Oxford University Press, which is used as a text in personalized and precision medicine courses at universities worldwide. He holds an MSc. and Ph.D. in Biomedical Informatics from Stanford University School of Medicine. Joel serves on the Scientific Advisory boards of numerous startups and companies in biotech and health tech.
Professor, Stockholm University
Erik Lindahl is Professor of Theoretical Chemistry and Stockholm University, Sweden. His research is focused on understanding structure and function of membranes and membrane proteins (the key workhorse molecules in all our cells), in particular by using molecular simulation in combination with experimental techniques to understand how atomic motions and interactions explain complex biological phenomena. His team develops GROMACS, which is one of the most widely used molecular dynamics simulations codes in the world, and they are also heavily engaged in using GPU technology to accelerate research discovery in fields such as cryo-electron microscopy.
Medical Officer, NCI
Gurvaneet Randhawa, M.D., M.P.H., is a Medical Officer in the Health Systems and Interventions Research Branch (HSIRB). Before joining NCI, he worked at the AHRQ for 13 years where he was a Medical Officer and a Senior Advisor on Clinical Genomics and Personalized Medicine. Prior to joining AHRQ, he completed his Preventive Medicine residency at Johns Hopkins University in 2002, which included a stint at NIAID. He completed an Internal Medicine internship at University of Pennsylvania in 2000. Prior to that, he trained for nine years in biomedical research at Johns Hopkins and at M.D. Anderson Cancer Center. His research interests at that time were in molecular biology and genomics with a focus on chronic myelogenous leukemia. He obtained his medical degree from Medical College, Amritsar, India.
Senior Investigator, NIH Radiology
Ronald M. Summers received the B.A. in physics and the M.D. and Ph.D. in Medicine/Anatomy & Cell Biology from the University of Pennsylvania. He completed a medical internship at the Presbyterian-University of Pennsylvania Hospital, Philadelphia, PA, a radiology residency at the University of Michigan, Ann Arbor, MI, and an MRI fellowship at Duke University, Durham, NC. In 1994, he joined the Diagnostic Radiology Department at the NIH Clinical Center in Bethesda, MD where he is now a tenured Senior Investigator and Staff Radiologist. He is currently Chief of the Clinical Image Processing Service and directs the Imaging Biomarkers and Computer-Aided Diagnosis (CAD) Laboratory. In 2000, Ronald received the Presidential Early Career Award for Scientists and Engineers, presented by Dr. Neal Lane, President Clinton's science advisor. In 2012, he received the NIH Director's Award, presented by NIH Director Dr. Francis Collins. His research interests include deep learning, virtual colonoscopy, CAD and development of large radiologic image databases. His clinical areas of specialty are thoracic and abdominal radiology and body cross-sectional imaging. He is a member of the editorial boards of the journals Radiology, Journal of Medical Imaging and Academic Radiology. He is a program committee member of the Computer-aided Diagnosis section of the annual SPIE Medical Imaging conference. He has co-authored over 400 journal, review and conference proceedings articles and is a co-inventor on 14 patents.
There are 14 million new cancer cases and 8.2 million cancer-related deaths worldwide per year.Innovation in the fight against cancer requires a multi-faceted approach. As patients and as stakeholders, healthcare ecosystem experts in genomics, proteomics, imaging, medicine and data sciences are cooperating in new ways. GPU computing, integrated data and novel algorithms enable the use of deep learning and artificial intelligence to transform cancer research and care. Dr. Jerry S.H. Lee, Whitehouse Cancer Moonshot Deputy Director for Research and Technology, will facilitate a thought provoking panel discussion on leveraging Artificial Intelligence to fight cancer.